Winners of the 2024 NACDS Total Store Expo Product Showcase Announced
The Product Showcase provides increased visibility for exhibiting suppliers to market their products to retailers.
NACDS Foundation Welcomes New Members to its Board of Directors
Directors from Viatris, Hy-Vee and Procter & Gamble to support the Foundation’s ongoing focus on research, education and scholarship programs.
Dr. Dariush Mozaffarian Receives “Cultivating Innovation in Care Award” at Annual NACDS Foundation Dinner
The NACDS Foundation presented the award at the 26th Annual NACDS Foundation Dinner, held at the Omni Boston Hotel at the Seaport during the 2024 NACDS Total Store Expo.
NACDS Leaders: Pharmacy is a Catalyst for Change and Innovation, and NACDS TSE is Where It Happens
2024 NACDS Total Store Expo welcomes NACDS chain and supplier members to Boston with impressive conference schedule; opportunities to come together to collaborate, innovate and confront industry pressures.
NACDS Foundation Dinner Raises More Than $1.35 Million to Advance Community Healthcare Through Partnerships in Research, Education and Philanthropy
The NACDS Foundation celebrated its 26th Annual Foundation Dinner in Boston, MA, on August 17.
NACDS Honors Member Pharmacies During National Immunization Awareness Month as Part of NACDS Nourish My Health Public Education Campaign
Social campaign underscores the importance of fall vaccinations to help manage infectious diseases.
Get Ready for the 2024 NACDS Total Store Expo
The 2024 National Association of Chain Drug Stores (NACDS) Total Store Expo kicks off August 17 in Boston, MA.
Morning Consult’s Eli Yokley Slated for NACDS TSE Political Event
Political analyst’s unique approach matches well with one of the most provocative Presidential elections ever
NACDS Political Involvement Reception will have the feel of a “bipartisan political convention rallying for all Americans and their pharmacies”
In Case You Missed It: NACDS Amplifies Major Congressional Hearing and Report Fueling ‘PBM Reform Now’
NACDS continues to urge the vital need for reforms at the federal level that will prevent “pharmaceutical benefit manipulation” across all markets – Medicare, Medicaid and commercial.
More Proof for PBM Reform: House Oversight Committee Issues Far-Reaching Report
Report: “The Committee’s findings indicate that the present role of PBMs in prescription drug markets is failing and requires change”
